GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Zymergen Inc (NAS:ZY) » Definitions » LT-Debt-to-Total-Asset

Zymergen (Zymergen) LT-Debt-to-Total-Asset : 0.38 (As of Jun. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Zymergen LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Zymergen's long-term debt to total assests ratio for the quarter that ended in Jun. 2022 was 0.38.

Zymergen's long-term debt to total assets ratio increased from Jun. 2021 (0.11) to Jun. 2022 (0.38). It may suggest that Zymergen is progressively becoming more dependent on debt to grow their business.

Zymergen LT-Debt-to-Total-Asset Historical Data

The historical data trend for Zymergen's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zymergen LT-Debt-to-Total-Asset Chart

Zymergen Annual Data
Trend Dec19 Dec20 Dec21
LT-Debt-to-Total-Asset
- - -

Zymergen Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.11 - - 0.29 0.38

Zymergen LT-Debt-to-Total-Asset Calculation

Zymergen's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2021 is calculated as

LT Debt to Total Assets (A: Dec. 2021 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2021 )/Total Assets (A: Dec. 2021 )
=0/522.396
=0.00

Zymergen's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jun. 2022 is calculated as

LT Debt to Total Assets (Q: Jun. 2022 )=Long-Term Debt & Capital Lease Obligation (Q: Jun. 2022 )/Total Assets (Q: Jun. 2022 )
=178.181/470.968
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zymergen  (NAS:ZY) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Zymergen LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Zymergen's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Zymergen (Zymergen) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Zymergen Inc (NAS:ZY) » Definitions » LT-Debt-to-Total-Asset
Comparable Companies
NTIC NANX CMT KBLB ODC CNEY BIOF GURE FSI STCB LIN XPAR:AI SHW APD ECL XSWX:SIKA LYB BOM:500820 DD IFF
Traded in Other Exchanges
N/A
Address
5980 Horton Street, Suite 105, Emeryville, CA, USA, 94608
Website
https://www.zymergen.com
Zymergen Inc is a biofacturing company. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of industries. A unique combination of biology, chemistry, software and automation enables the company to design and create new materials.
Executives
Enakshi Singh officer: Chief Financial Officer 5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Mina Kim officer: Chief Legal Officer C/O ACELYRIN, INC., 4149 LIBERTY CANYON RD., AGOURA HILLS CA 91301
Zachariah Serber director, officer: Chief Science Officer 5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Aaron Kimball officer: Chief Technology Officer 5980 HORTON ST., STE 105 EMERYVILLE CA 94025
Jay T Flatley director 9885 TOWNE CENTRE DR, SAN DIEGO CA 92121
Svf Excaliber (cayman) Ltd 10 percent owner 27 HOSPITAL ROAD, WALKERS CORPORATE LTD., CAYMAN CORPORATE CENTRE, GEORGE TOWN, GRAND CAYMAN E9 KY-9008
Josh Hoffman director, officer: Chief Executive Officer 5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Erik Jedidiah Dean officer: VP Operations and Engineering 5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Rohit Sharma director 575 HIGH STREET PALO ALTO CA 94301
Travis Murdoch director 1 CIRCLE STAR WAY SAN CARLOS CA 94070
Matthew Ocko director 270 UNIVERSITY AVENUE, PALO ALTO CA 94301
Svf Endurance (cayman) Ltd 10 percent owner C/O WALKERS CORPORATE LIMITED, 27 HOSPITAL ROAD, GEORGE TOWN E9 KY1-9008
Softbank Vision Fund (aiv M1) L.p. 10 percent owner 251 LITTLE FALLS DRIVE, WILMINGTON DE 19808
Sb Investment Advisers (uk) Ltd 10 percent owner 69 GROSVENOR STREET, LONDON X0 W1K 3JP
Christine Marie Gorjanc director 4500 GREAT AMERICA PARKWAY, SANTA CLARA CA 95054